DBT pseudogene 1 (DBTP1)

DBT pseudogene 1 (DBTP1) is a non-protein-coding pseudogene related to the functional DBT gene, encoding dihydrolipoamide branched chain transacylase E2. Pseudogenes like DBTP1 often share sequence similarity with their functional counterparts, but accumulate disabling mutations and typically lack protein production[4]. While pseudogenes have attracted attention for possible roles in gene regulation through RNA mechanisms such as miRNA decoys or competing endogenous RNA, there is no published research indicating such a role for DBTP1 specifically[3]. Unlike the functional DBT protein, which is involved in mitochondrial branched-chain amino acid metabolism, DBTP1 does not participate in canonical biological or disease-related pathways[4]. No orthologs, protein products, interacting drugs, or known disorders are associated with DBTP1[4]. In summary, DBTP1 is a genomic pseudogene with no demonstrated functional, therapeutic, or biomarker relevance. It is not considered a receptor, enzyme, or drug target. The query appears to be based on a misidentified or non-functional entity[4][3].

Other names

DBT pseudogene 1DBTP1

None — As a pseudogene, it does not have a drug-targetable mechanism.